Coagulopathy biomarkers including increased D-dimer, fibrinogen degradation products (FDP), decreased fibrinogen, prolonged prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT) were indicators of coagulation disorders. This evidence concerns the gene F2 and blood coagulation disease.